UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED CONDENSED STATEMENT OF CASH FLOW - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 4,452	$ 6,664
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation	335	355
Amortization	3,242	2,902
Provision for (recovery of) losses on accounts receivable	(14)	(2)
Amortization of Right of Use Assets	19	19
Deferred income taxes	51	(278)
Stock-based compensation expense	72	56
Tax benefit attributable to exercise of stock options	7	15
Changes in operating assets and liabilities:
Accounts receivable and other receivables	903	(1,256)
Inventories	387	(2,322)
Prepaid expenses and other current assets	40	24
Accounts payable	(528)	(123)
Accrued expenses	385	(1,011)
Total adjustments	4,899	(1,621)
Net cash provided by operating activities	9,351	5,043
CASH FLOWS FROM INVESTING ACTIVITIES:
Property and equipment	(711)	(130)
Intangible assets	0	(21,000)
Net cash used in investing activities	(711)	(21,130)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock - options	79	171
Common stock purchased and retired	(6,426)	(398)
Payment of dividends	(2,077)	(2,055)
Net cash used in financing activities	(8,424)	(2,282)
Effect of exchange rate changes on cash	(651)	137
Net decrease in cash and cash equivalents	(435)	(18,232)
Cash at beginning of period	42,787	51,112
Cash at end of period	42,352	32,880
Cash paid during the period for income taxes	786	2,937
Cash paid during the period for interest	$ 0	$ 0